| __timestamp | Lantheus Holdings, Inc. | Merck & Co., Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 301600000 | 42237000000 |
| Thursday, January 1, 2015 | 293461000 | 39498000000 |
| Friday, January 1, 2016 | 301853000 | 39807000000 |
| Sunday, January 1, 2017 | 331378000 | 40122000000 |
| Monday, January 1, 2018 | 343374000 | 42294000000 |
| Tuesday, January 1, 2019 | 347337000 | 46840000000 |
| Wednesday, January 1, 2020 | 339410000 | 41518000000 |
| Friday, January 1, 2021 | 425208000 | 48704000000 |
| Saturday, January 1, 2022 | 935061000 | 59283000000 |
| Sunday, January 1, 2023 | 1296429000 | 60115000000 |
Unleashing insights
In the ever-evolving pharmaceutical landscape, revenue performance is a key indicator of a company's market position and growth potential. Over the past decade, Merck & Co., Inc. has consistently demonstrated its dominance, with revenues soaring by approximately 42% from 2014 to 2023. In contrast, Lantheus Holdings, Inc. has shown remarkable growth, with a staggering 330% increase in the same period, albeit from a smaller base.
Merck's revenue, peaking at around $60 billion in 2023, underscores its robust market presence and strategic initiatives. Meanwhile, Lantheus, with its revenue reaching nearly $1.3 billion, highlights its rapid expansion and potential in niche markets. This comparison not only showcases the giants of the industry but also the rising stars, offering insights into the dynamic shifts within the pharmaceutical sector.
Johnson & Johnson and Merck & Co., Inc.: A Comprehensive Revenue Analysis
Breaking Down Revenue Trends: Merck & Co., Inc. vs Teva Pharmaceutical Industries Limited
Comparing Revenue Performance: Merck & Co., Inc. or Halozyme Therapeutics, Inc.?
Gross Profit Analysis: Comparing Merck & Co., Inc. and Lantheus Holdings, Inc.
Merck & Co., Inc. vs Dynavax Technologies Corporation: Examining Key Revenue Metrics
Merck & Co., Inc. vs Celldex Therapeutics, Inc.: Examining Key Revenue Metrics
Vertex Pharmaceuticals Incorporated vs Lantheus Holdings, Inc.: Examining Key Revenue Metrics
Takeda Pharmaceutical Company Limited vs Lantheus Holdings, Inc.: Examining Key Revenue Metrics
Genmab A/S or Lantheus Holdings, Inc.: Who Leads in Yearly Revenue?
Lantheus Holdings, Inc. and Ionis Pharmaceuticals, Inc.: A Comprehensive Revenue Analysis
Lantheus Holdings, Inc. and ImmunityBio, Inc.: A Comprehensive Revenue Analysis
Revenue Showdown: Lantheus Holdings, Inc. vs Evotec SE